Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. [electronic resource]
Producer: 20050712Description: 880-7 p. digitalISSN:- 1460-2105
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Area Under Curve
- Dacarbazine -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- ErbB Receptors -- drug effects
- Erlotinib Hydrochloride
- Female
- Glioma -- drug therapy
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Male
- Middle Aged
- Mutation
- PTEN Phosphohydrolase
- Phosphoric Monoester Hydrolases -- drug effects
- Phosphorylation
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt
- Quinazolines -- administration & dosage
- Supratentorial Neoplasms -- drug therapy
- Temozolomide
- Tumor Suppressor Proteins -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.